Recent clinical trials summary

Daniel R. Nathanson, Charles Thomas, Ronald Bleday

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

The current standard of care for the treatment of anal cancer as demonstrated by all of the completed phase 3 clinical trials remains 5-FU and mitomycin C in combination with radiation therapy. The basic elements of the approach outlined by Nigro have not changed in the last 30 years. Future phase 3 trials will serve to further perfect this approach and outline the role of HPV and dysplasia in the development and progression of this disease.

Original languageEnglish (US)
Pages (from-to)389-394
Number of pages6
JournalSurgical Oncology Clinics of North America
Volume13
Issue number2
DOIs
Publication statusPublished - Apr 2004
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this